VENUTA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 360
EU - Europa 91
AS - Asia 80
SA - Sud America 1
Totale 532
Nazione #
US - Stati Uniti d'America 346
IT - Italia 54
CN - Cina 38
SG - Singapore 38
SE - Svezia 20
CA - Canada 14
GB - Regno Unito 8
DE - Germania 4
IR - Iran 2
AT - Austria 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
FI - Finlandia 1
KR - Corea 1
NL - Olanda 1
SA - Arabia Saudita 1
Totale 532
Città #
Chandler 73
Ashburn 40
Singapore 32
Santa Clara 21
Milan 19
Princeton 19
Lawrence 18
Ottawa 14
Wilmington 13
Catanzaro 12
Chicago 10
Boardman 9
London 8
Washington 7
Des Moines 6
Guangzhou 6
Shanghai 5
Redmond 4
Forlì 3
Hanover 3
Los Angeles 3
Palermo 3
Rende 3
Beijing 1
Clifton 1
Hebei 1
Helsinki 1
Irsina 1
Jiaxing 1
La Canada Flintridge 1
Laojunmiao 1
Munich 1
Nanjing 1
Naples 1
Napoli 1
Riyadh 1
Rome 1
Rui'an 1
Seattle 1
Secaucus 1
Seoul 1
Shenzhen 1
Wuxi 1
Totale 351
Nome #
A novel Q3034R BRCA2 germline mutation identified in a fallopian tube cancer patient 50
A proteomics approach to identify changes in protein profiles in serum of Familial Adenomatous Polyposis patients 40
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer 40
A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy 39
Detection and functional analysis of an SNP in the promoter of the human ferritin H gene that modulates the gene expression 39
Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation 32
Transcriptional regulation of the mismatch repair gene hMLH1 32
Proteomic profiling of inherited breast cancer: Identification of molecular targets for early detection, prognosis and treatment, and related bioinformatics tools 29
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 28
An alternative model of H-ferritin promoter transactivation by c-Jun 28
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 27
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 24
Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles 24
p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y 22
Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo 22
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 19
Induction of tumorigenicity and plasmacytoid differentiation in EBV-B cells by expression of exogenous interleukin-6 or IL-6 receptor genes. 18
In Vitro Analysis of Genomic Instability Triggered by BRCA1 Gene Missense Mutations 18
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu in vivo model of human multiple myeloma 18
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 16
Totale 565
Categoria #
all - tutte 7.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 1 13
2020/202119 1 0 0 0 0 10 1 0 3 1 2 1
2021/202267 0 1 5 18 2 0 3 16 6 6 9 1
2022/2023210 40 14 10 12 20 19 28 12 32 7 12 4
2023/2024124 13 17 17 11 9 25 2 16 1 1 1 11
2024/2025130 38 17 21 4 24 26 0 0 0 0 0 0
Totale 565